Results 61 to 70 of about 173,777 (119)

Reconsidering the Classification of YTHDF2 in Glioblastoma [Letter]. [PDF]

Int J Nanomedicine
Sikorski V, Salo J.
europepmc   +1 more source

Translational Challenges and Strategies for Antibody Therapeutics in Glioblastoma. [PDF]

Curr Oncol
Zhou Y, Li Y, Chen Y, Zhao P, Wang B, Zhu H, Sun H, Zhang T, Zhang A, Pan Y, Wang K.   +10 more
europepmc   +1 more source

Integrated transcriptomic and single-cell analyses define neuronal heterogeneity and PDIA4-associated malignancy in glioblastoma. [PDF]

Front Oncol
Liu Z, Luo X, Deng X, Liu Y, Wu W.
europepmc   +1 more source

Early extracranial dissemination with prolonged survival in IDH-wildtype glioblastoma: case study and comprehensive literature review. [PDF]

CNS Oncol
Burns C, Wu CC, Suzuki K, Lee G, Kim D.
europepmc   +1 more source

Progesterone Receptor Expression in Different Regions of Glioblastoma Multiforme and in an In Vitro Model. [PDF]

Int J Mol Sci
Szubert D, Kojder K, Jeżewski D, Tarnowski M, Tomasiak P, Piotrowska K, Kolasa A, Bosiacki M, Szućko-Kociuba I, Kołodziejczak M, Kapczuk P.   +10 more
europepmc   +1 more source

Nuclear Eccentricity as a Potential Biomarker for Tumor Biology and Survival in Glioblastoma. [PDF]

Curr Oncol
Han L, John T, Hassan M, Wisco JJ.
europepmc   +1 more source

Vascular habitat analysis using dynamic susceptibility contrast-enhanced perfusion MRI for differentiating glioblastoma from solitary brain metastases. [PDF]

Front Oncol
Li X, Wang H, Zeng L, Zhao M, Feng L, Xie H, Ran Q, Ma Q, Wang S.   +8 more
europepmc   +1 more source

LncRNA CCDC152 coordinates a tumor-associated selenoprotein P cycle that sustains selenium-dependent redox homeostasis in glioblastoma. [PDF]

Redox Biol
Siu S, Taguchi H, Zheng X, Sugiura H, Yamashita S, Takahashi T, Kosuge M, Kaneko T, Shimizu M, Shimoda Y, Noritsugu K, Arisawa K, Watanabe M, Toyama T, Kanamori M, Endo H, Saito Y.   +16 more
europepmc   +1 more source

Single-cell RNA sequencing combined with artificial intelligence to uncover immunotherapy biomarkers and decipher drug resistance mechanisms in glioblastoma. [PDF]

Front Oncol
Fu T, Hu M, Wu X.
europepmc   +1 more source

Targeting NOTCH-immune crosstalk in gliomas: from mechanisms to therapeutics. [PDF]

Front Oncol
Ebrahimi S, Meshkinkhood N, Aliee A, Yuhan L, Koulivand M, Koulivand Z, Gorji A.   +6 more
europepmc   +1 more source